From Medscape Neurology

Coverage from the

Consortium of Multiple Sclerosis Centers (CMSC) 2018 Annual Meeting

May 30 - June 02, 2018; Nashville, Tennessee

May 30 - June 02, 2018 Nashville, Tennessee

Conference News

CMSC 2018 Subjective Reports Positive for Cannabis in MS, but Caution Urged
Medscape Medical News, June 13, 2018
CMSC 2018 Legit Stem Cell Therapies Advance as Bogus Clinics Proliferate
Medscape Medical News, June 11, 2018
CMSC 2018 Gut Bacteria, Diet Significant in Multiple Sclerosis
Medscape Medical News, June 5, 2018
CMSC 2018 Improved Disability, Cognition With Ocrelizumab in MS
Medscape Medical News, June 4, 2018

CMSC 2018 Alemtuzumab Benefits in MS Maintained at 7 Years
Medscape Medical News, June 4, 2018
CMSC 2018 Benefits of MS Group Cognitive Intervention Extend to Depression
Medscape Medical News, June 1, 2018
CMSC 2018 DMTs, Cognitive Issues in the Spotlight at CMSC
Medscape Medical News, May 29, 2018

Popular News from CMSC 2017

Discontinuing Disease-Modifying Therapy in MS A literature review suggests stopping therapy might be considered in certain subsets of patients later in the disease course, researchers say. Others call the idea 'dangerous.'
Medscape Medical News, May 29, 2017
Should All Patients With MS Receive Aggressive Treatment? With numerous agents for multiple sclerosis seemingly more effective than older drugs in halting disease activity, can a case be made for starting all newly diagnosed patients on them?
Medscape Medical News, Jun 01, 2017
Revisions Underway to McDonald Criteria on MS Diagnosis An expert panel is tackling the first revision to the multiple sclerosis diagnostic criteria in 7 years. Among proposed changes is a greater role for cerebrospinal fluid evaluation.
Medscape Medical News, May 26, 2017

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

CMSC on Twitter

#CMSC2018 Tweets

Previous Coverage

Related Resource

Multiple Sclerosis News & Perspectives